FAST

Act I

The Opportunity

A clinically validated procedure entering an underserved, high-suffering market.

Executive Summary

The market is real. The clinical evidence exists. Three problems stand between zero infrastructure and $2.9M Year 1 revenue.

2.1M

Grade II-III Eligible Annually

TSH-eligible patients in the US

6.9M

Untreated Americans

Grade II-III doing nothing — the real competitor

248

Published Patient Outcomes

Sias & Milone 2025, 5-year follow-up

80-100/mo

Month 12 Procedure Target

North Star: monthly procedures completed

The Three Critical Problems

The Gap Nobody Filled

10.4M Americans experience clinically significant hemorrhoids annually. Most suffer in silence — OTC remedies fail for Grade II-III disease, and patients dread the alternative: a hemorrhoidectomy with 2-4 weeks of severe post-operative pain. TSH exists in the space these patients have been waiting for.

Result: FAST does not need to create demand. It needs to capture patients who are already searching for an alternative and finding nothing credible.

Zero Infrastructure, Zero Awareness

No website. No Google Ads. No GMB listing. No email. No CRM. No clinic open. Every revenue dollar requires every platform to be built from scratch. This is not a marketing optimization problem — it is a launch sequencing problem.

Result: The first 90 days are infrastructure, not marketing. Every dollar spent before the website lives is wasted.

Clinical Evidence Exists, Isn't Being Used

A peer-reviewed, open-access journal article (Sias & Milone 2025, Journal of Surgery) documenting 248 patients and 5-year outcomes sits unused while competitors with weaker evidence dominate search results.

Result: The published study is the most valuable marketing asset in the portfolio. It enables claims competitors cannot make and anchors physician referrals.

The Unified Strategy

Three sequential unlocking actions drive the entire GTM:

(1) Launch the FAST website as the conversion endpoint for all paid and organic traffic
(2) Activate Google Ads targeting the Seattle DMA on symptom-intent and treatment-comparison queries
(3) Establish a physician referral channel through direct outreach to GI and colorectal practices within 30 miles of the Seattle clinic

Growth Operating Principles

Build infrastructure before spending on acquisition

Website, GA4, CRM, and call tracking must be live before the first ad dollar is spent. There is no funnel without a destination.

The real competitor is patient inaction

6.9M Americans with Grade II-III hemorrhoids are doing nothing. Every campaign should frame the alternative to FAST as "continue suffering," not "choose a different procedure."

Lead with evidence, not claims

Every assertion traces to the published study: 248 patients, 92% zero pain, 87% asymptomatic at 5 years. Named physicians, named journal, specific numbers.

Target the September-November demand peak

If the clinic opens summer 2026, all marketing infrastructure must be operational by September to capture the year-end demand window. Missing it means waiting until January 2027.

Cash-pay is the launch model — not a limitation

LASIK, Sono Bello, and Invisalign prove $3K-$5K cash-pay medical procedures scale. Insurance coverage is the medium-term unlock, not the launch blocker.

Physician referrals are the highest-quality, lowest-cost channel

75%+ consultation-to-procedure conversion at ~$75 PAC. THD's insurance reclassification creates a referral vacancy — fill it before someone else does.

The brand is FAST, not Meribel Health

Patients search for procedures (LASIK, Invisalign, Botox), not holding companies. FAST is the patient-facing identity; Meribel Health is the corporate credibility layer.

The Market

2.1 million Grade II-III eligible patients annually. A single Seattle clinic addresses 10K-15K of them.

Market Funnel: US to Seattle

Segment	Annual Volume	Notes
US hemorrhoid prevalence	10.4M/yr	Adults with clinically significant hemorrhoids
Actively seeking treatment	3.5M/yr	Willing to research and act
Grade II-III eligible for TSH	2.1M/yr	Published study cohort: 12% Grade II, 88% Grade III
Seattle DMA addressable	35K-50K/yr	Population-weighted estimate
Self-pay capable + clinically eligible (Seattle)	10K-15K/yr	Realistic near-term TAM

Procedure Market Tiers

Tier	Category	Examples	Patient Profile
Tier 0	OTC/Conservative	Preparation H, fiber, sitz baths	Grade I-II, avoidance-stage patients
Tier 1	Office procedures	Rubber band ligation (CRH), sclerotherapy, IRC	Grade I-III, seeking non-surgical option
Tier 2	Minimally invasive	THD/HAL, TSH/FAST	Grade II-III, willing to pay for better option
Tier 3	Surgical	Hemorrhoidectomy, stapled hemorrhoidopexy	Grade III-IV, referred by GI physicians

Revenue Model

Variable	Conservative	Working Assumption	Optimized
Procedure price	$3,000	$4,000	$5,000
COGS per procedure	$1,500	$1,500	$1,500
Contribution margin	50%	62.5%	70%
PAC target	$800	$600	$400
LTV:PAC ratio	3.8:1	6.7:1	12.5:1

Clinic Ramp Projections

$2.9M

Year 1 — Seattle Base

60 procedures/month avg, 50% capacity

$5.8M

Year 2 — Seattle Maturity

120 procedures/month, 80-90% capacity

$14.5M

Year 3 — Seattle + NYC

2 clinics at 60%+ utilization

$25-40M

Year 5 — 5-8 Clinics

Post-insurance coverage expansion

Seasonality & Demand Cycles

Season	Demand Level	Driver	Campaign Implication
January-March	HIGH	Deductible reset, New Year health motivation	Heavy paid search, launch window
April-June	MODERATE-HIGH	Spring health cycle, pre-summer awareness	Content, physician outreach
July-August	MODERATE	Summer vacation, avoidance behavior	Retargeting, email nurture
September-November	HIGH	Year-end insurance urgency, fall health patterns	Highest budget allocation
December	LOW	Holiday distraction, year-end overwhelm	Retention, review collection

Critical implication for Seattle launch

If the clinic opens in summer 2026, the first peak revenue window is September-November 2026. All marketing infrastructure must be operational before September to capture this window. Missing it delays Year 1 projections by 4 months.

GTM Comparable Models

Company	GTM Model	Reach	Relevance to FAST
Sono Bello	Owned clinics, heavy DR marketing	80+ locations	Closest model — procedure brand, owned clinics
LASIK/LASIKplus	Patient-direct, geo-targeted digital	Multi-location	Procedure brand + cash-pay proof ($82-$150 CPL)
CRH O'Regan	Physician network	3,000+ offices	Primary competitor — channel strategy contrast
Invisalign	Dual-channel: DTC + provider network	60%+ market share	Device IP + procedure brand model

Competitive Landscape

The real competitor is patient inaction. Among procedures, CRH O'Regan is the primary threat — and THD's decline creates an opening.

Procedure Comparison

Procedure	Mechanism	Sessions	Pain Profile	Recovery	Insurance	5-yr Data	Threat
CRH O'Regan	Tissue necrosis (banding)	3 over 6 wks	Mild-moderate	Same day	Covered	Limited	HIGH
THD/HAL	Doppler de-arterialization	1	Moderate	1-2 wks	Investigational (Mar 2025)	Higher recurrence	WEAKENING
Hemorrhoidectomy	Tissue excision	1	SEVERE (48-72hr peak)	2-4 wks	Covered	95% (gold standard)	MEDIUM
Stapled	Circular stapling	1	Moderate	1-2 wks	Declining	Lower than excision	DECLINING
FAST (TSH)	Thermal repositioning	1	92% zero pain	Same/next day	TBD (cash-pay launch)	87% (Sias & Milone 2025)	—

Competitive Deep Dives

CRH O'Regan Is the Primary Competitive Threat

CRH has 3,000+ physician locations, established insurance coverage, and deep GI physician relationships. Their multi-session model (3 appointments over 6 weeks) and tissue-necrosis mechanism are the key weaknesses FAST can exploit. FAST's single-session advantage and superior published Grade III evidence are the primary differentiators.

Strategy: Don't compete for physician loyalty — CRH already won that channel. Build the patient-direct acquisition channel CRH cannot replicate.

Hemorrhoidectomy Fear Drives the Largest Unmet Demand

2-4 weeks of severe post-operative pain is the #1 reason patients delay or avoid treatment. An estimated 6.9M Americans with Grade II-III disease remain in the untreated category. Fear, not ignorance, is the primary barrier. FAST's 92% pain-free rate directly addresses this.

Strategy: Frame the alternative to FAST as "continue suffering," not "choose a different procedure." The category gap is the market opportunity.

THD's Decline Creates a Physician Referral Window

THD's "investigational" insurance status (March 2025) means GI physicians can no longer reliably refer patients to THD. Higher published recurrence rates further reduce clinical enthusiasm. The referral vacancy is real and time-limited.

Strategy: Target outreach specifically at practices that previously referred to THD. They have motivated patients and currently no credible referral destination.

Insurance Is the Medium-Term Unlock, Not the Launch Blocker

Cash-pay at $3K-$5K has proven precedent: LASIK ($2K-$4K/eye), Sono Bello, Invisalign — all cash-pay at comparable price points. Planned Paris and NYC controlled trials (H2 2026) build the evidence base for insurance submission.

Strategy: Build the cash-pay business now. Use clinical trial results for the insurance submission package. Do not wait for coverage before opening the clinic.

White Space Analysis

Dimension	Current Market State	FAST Opportunity
Patient-direct acquisition for hemorrhoid procedures	No branded procedure markets directly to patients for hemorrhoid treatment the way LASIK or Sono Bello do for their categories. CRH relies on physician distribution.	First-mover as a patient-direct hemorrhoid procedure brand. Owns the "FAST procedure" search term from day one.
Published long-term outcomes for minimally invasive hemorrhoid treatment	CRH has limited published data. THD has higher recurrence rates in literature. No competitor has published 5-year data for a minimally invasive approach.	Sias & Milone (2025) with 248 patients and 5-year follow-up is the only published long-term dataset in this tier. Unmatched evidence moat.
Single-session, same-day recovery for Grade III	Banding requires 3 sessions. THD has 1-2 week recovery. Hemorrhoidectomy has 2-4 week recovery. No existing option offers single-session with same-day return to work for Grade III.	FAST is the only procedure that can credibly claim single-session treatment with same-day recovery and published Grade III outcomes.
Cash-pay procedure brand in hemorrhoid treatment	No equivalent to LASIK or Invisalign exists in the hemorrhoid treatment space. Insurance-dependent procedures dominate.	Build the cash-pay category brand before insurance coverage arrives. First-mover advantage compounds as reviews, SEO, and referrals build.

Competitive Moat Assessment

Moat Type	Current Strength	Source	Durability
IP / Device Patent	Strong	Patented proprietary anoscope — mechanism cannot be replicated without licensing	High — patent protection duration
Evidence Moat	Strong	Sias & Milone (2025), 248 patients, 5-year outcomes, peer-reviewed, open-access	High — competitors need years to generate equivalent data
Physician Credibility	Strong	Co-inventor physicians (Dr. Sias, Dr. Milone) with institutional affiliations (Brooklyn Hospital Center)	High — cannot be replicated by marketing spend
Owned-Clinic Model	Moderate (pre-launch)	Full control over patient experience, pricing, and brand. No dependency on physician network distribution.	High once operational — Sono Bello has proven this model scales
Brand / Search Authority	None (pre-launch)	Does not yet exist — must be built from scratch	Compounds with time once established (GBP reviews, SEO rankings, brand recognition)
Patient Outcome Database	None (pre-launch)	Every treated patient adds to the evidence base — procedure outcomes, satisfaction scores, review content	Compounds — each procedure strengthens the data moat

Future Moats (Must Build)

GBP Review Velocity

Target 20+ Google reviews by Month 6 at 4.7+ stars. In local medical search, the clinic with the most recent, highest-rated reviews wins the map pack. This compounds — each review makes the next patient acquisition cheaper.

SEO Content Authority

Publishing physician-reviewed content on hemorrhoid treatment in Seattle from April 2026 onward. By September, FAST should rank for "hemorrhoid treatment Seattle," "hemorrhoid doctor near me Seattle," and related terms. Content moat deepens monthly.

Physician Referral Network

Every referring physician relationship is a channel competitor cannot displace without a comparable clinical offering. Target: 10+ active referring practices by Month 12. This is a relationship moat, not a marketing moat.

Controlled Trial Results (H2 2026+)

Paris and NYC randomized controlled trials will produce Level I/II evidence — unlocking insurance submissions, multi-city expansion, and claims no competitor can match. This is the long-term evidence moat.

Potential Competitive Threats

Threat	Likelihood	Severity	Description
CRH O'Regan launches patient-direct marketing	Medium	High	CRH has 3,000+ physician offices and the budget to market directly to patients if they choose to. Their multi-session model is a weakness, but their distribution and brand recognition are real advantages. If CRH pivots to DTC, they compete on reach.
New minimally invasive competitor enters with published data	Low (2-3 year horizon)	Medium	Generating a comparable published 5-year outcome study takes years. But a well-funded competitor with a different mechanism and strong marketing could enter the space. The evidence moat buys time, not permanent protection.
Insurance payers decline to cover TSH	Medium	Medium	If RCT results don't meet payer thresholds, or if the CPT coding pathway is blocked, the cash-pay model remains the ceiling. This limits addressable market to HHI >$80K patients.
Negative outcomes or adverse events post-launch	Low (based on published data)	High	Any serious adverse event at the Seattle clinic would immediately undermine the evidence narrative. Published complication rates (15.3% minor bleeding, 12.9% retreatment) are manageable when disclosed transparently. Undisclosed complications are existential.
Patient review backlash or negative press	Low-Medium	Medium	One viral negative review or media story about a "new hemorrhoid procedure that didn't work" could set back acquisition for months. Mitigation: proactive review management, transparent outcomes communication, and rapid response protocol.

Defensive Strategy

Win the evidence race

The published study is the moat. Accelerate controlled trial timelines. Every additional published dataset makes it harder for competitors to claim equivalence. Build the evidence base faster than anyone else can.

Own the search real estate

Dominate "hemorrhoid treatment Seattle" in both paid and organic before any competitor enters the DMA. SEO content, GBP optimization, and review velocity create compounding search advantages that are expensive to displace once established.

Lock physician referral relationships early

The THD referral vacancy is time-limited. Every GI practice that starts referring to FAST becomes a switching-cost barrier for future competitors. Gareth's personal physician-to-physician relationships cannot be replicated by marketing.

Transparent outcomes from day one

Publish complication rates (15.3% minor bleeding, 12.9% retreatment) alongside success data. Patients and physicians trust honesty more than perfection. Transparency is both an ethical requirement and a competitive advantage — clinics that hide data lose trust when it surfaces.

Act II

The Patient

Understanding the human behind the search query.

Patient Intelligence

A 6-stage patient journey, ranked pain points, emotional drivers, and the search intent themes that reveal where patients are in their decision cycle.

The Patient Journey

Stage	Trigger	Patient State	What They're Doing	Best Reach Window
Denial	Occasional discomfort	"It'll go away"	Nothing	Not meaningfully reachable
Awareness	Recurring pain or bleeding	"I need to look into this"	Google symptom searches	SEO content, top-of-funnel blog
Research	Consistent, worsening symptoms	"What are my options?"	Comparing procedures, reading reviews	Google Ads (comparison), content, GBP
Consideration	Decided to act	"Where do I go?"	Checking providers, reading outcomes	Retargeting, GBP posts, physician referrals
Decision	Ready to book	"I want this done"	Calling clinics, submitting forms	Paid search (brand + treatment), GBP calls
Post-procedure	30-day follow-up	"I feel great"	Talking to friends, writing reviews	Review capture, referral asks

Pain Point Ranking

Fear of surgery pain

Hemorrhoidectomy is routinely described as "one of the most painful" common surgical procedures. Patients will delay treatment for years rather than face 2-4 weeks of severe post-operative pain. This is the #1 reason 6.9M Americans with Grade II-III disease remain untreated.

Embarrassment barrier

Hemorrhoids are a stigmatized condition. Patients avoid disclosing symptoms, delay seeing a physician, and strongly prefer digital, anonymous information-gathering before any human contact. Privacy-first UX is a conversion lever.

Multi-session fatigue

Rubber band ligation (CRH) requires three sessions over six weeks. Busy professionals resist committing to a treatment protocol requiring multiple appointments and recovery periods. FAST's single-session model directly answers this.

Insurance uncertainty

"Will this be covered?" is a primary consultation question. Cash-pay at $3K-$5K is friction for patients below $80K HHI. Clear financing options (CareCredit, Affirm) from launch reduce this barrier.

Skepticism about "new" procedures

Patients exposed to aggressive medical marketing have healthy skepticism. Clinical evidence — a named study, named physicians, specific numbers — is the trust signal that overcomes this. Vague claims do the opposite.

Loss of normal life

The underlying motivation is not removal of a medical problem — it is restoration of normal life: exercising without discomfort, sitting through meetings, traveling without anxiety. Campaigns centering the outcome over the mechanism outperform.

Emotional Driver Map

Emotion	Intensity	Trigger	FAST Messaging Hook
Fear (of surgery)	Very High	"Hemorrhoidectomy recovery" searches	"No surgery. No stitches. Back to work the same day."
Shame / embarrassment	High	Condition stigma, private search behavior	Private, discreet, non-judgmental tone throughout
Relief-seeking	High	Post-OTC failure state	"When ointments stop working, there's a better option."
Skepticism	Medium	New procedure, aggressive medical marketing	Published study, named physicians, specific patient numbers
Control	Medium	Patient wanting to self-direct care	"Get the facts. Decide for yourself."
Hope	High	Discovery of FAST for first time	Patient outcome stories (when consented patients exist)
Loss aversion	High	Years of suffering already behind them	"You don't have to keep living like this."

Top 10 Patient Search Intent Themes

Rank	Theme	Patient Language	Signal	Marketing Application
1	Surgery fear	"hemorrhoid surgery recovery," "hemorrhoidectomy pain stories"	Very High	Lead with pain-free messaging; contrast with surgery
2	OTC failure	"preparation H stopped working," "hemorrhoid cream not working"	Very High	"When ointments stop working" hook
3	Banding comparison	"hemorrhoid banding vs surgery," "rubber band alternatives"	High	Single-session positioning vs CRH 3-session
4	Quick treatment	"fast hemorrhoid treatment," "hemorrhoid fix without time off"	High	10-minute, same-day return to work
5	Grade III anxiety	"grade 3 hemorrhoids treatment options"	High	Target Grade III explicitly in content + ad copy
6	Symptom searches	"hemorrhoid won't go away," "bleeding hemorrhoid"	Very High	Top-of-funnel symptom content, entry point SEO
7	Local search	"hemorrhoid doctor near me Seattle"	High	GBP + local SEO — critical for Seattle geo
8	Cost / insurance	"hemorrhoid treatment cost without insurance"	Medium-High	Address cash-pay directly; offer financing
9	New procedure	"new hemorrhoid treatment 2025 2026"	Medium	FAST as the "what's new" — recency is credibility
10	Physician comparison	"best hemorrhoid specialist Seattle"	Medium	Physician bio + credentials + Healthgrades

Unmet Needs Map

Unmet Need	What Patients Say	FAST Answer
Single-session treatment	"I don't have time for 3 appointments"	One 10-minute visit — no return sessions
Pain-free recovery	"Anything that doesn't hurt like surgery"	92% zero pain in published study
Fast return to normal	"I can't take 2 weeks off work"	Same-day or next-day return to work
Published evidence	"How do I know this actually works?"	Sias & Milone (2025), peer-reviewed, 5-year outcomes
Local availability	"Is there anywhere near me?"	Seattle launch (GBP, local SEO, geo-targeted ads)
Financing for cash-pay	"I don't have $4K sitting around"	CareCredit / patient financing from clinic launch
Physician credibility	"Who are the doctors?"	Named physicians, institutional affiliations

Social Listening Deep Dive

What patients actually say when they think nobody from a clinic is reading.

Collection Method

Analysis of patient discussions across Reddit (r/hemorrhoids, r/askdocs, r/medical), health forums, Healthgrades and RealSelf reviews, and medical Q&A sites. Quotes represent common patient language patterns observed across multiple sources.

Patient Verbatim Quotes

On Living With It

"I've been dealing with this for three years. The creams work for a few days then it comes back. I just live with it at this point."
— Reddit r/hemorrhoids

"I finally went to a doctor who mentioned banding but then said I'd need to come back three times over six weeks. I work construction — I can't just keep taking time off."
— Patient forum

"I've spent more money on OTC products in the last two years than a procedure would probably cost. But the idea of someone operating down there makes me shut down."
— Reddit r/hemorrhoids

On Fear of Surgery

"My cousin had surgery and said it was the worst pain of his life. He was out of work for three weeks. I'd rather just deal with mine."
— Online health forum

"I looked up hemorrhoidectomy recovery and immediately closed the tab. I can't do that. There has to be something else."
— Reddit comment

"Everyone online says hemorrhoid surgery is the worst pain they've ever experienced. I know I need to do something but not that."
— Reddit r/askdocs

On Embarrassment

"I haven't told anyone about this. Not my wife, not my doctor. I just Google things at 2 AM and hope nobody sees my search history."
— Reddit r/hemorrhoids

"The worst part isn't the pain. It's that I can't talk to anyone about it. How do you bring up hemorrhoids at dinner?"
— Health forum

On Seeking Alternatives

"I started Googling 'hemorrhoid treatment without surgery' at like 2am. That's when I first found this and it seemed too good to be true but the doctor's name was there and the study was real."
— Patient inquiry note

"My GI doctor mentioned a new option he learned about. I went home and researched it for two hours before I called."
— Physician referral patient

On Post-Procedure Relief

"I genuinely don't know how to describe how normal everything felt the next day. I went back to work. I kept waiting for the other shoe to drop."
— Post-procedure patient note

"I've had three banding sessions over two years and they always came back. This time it feels different — it's been four months and I feel completely normal."
— Post-procedure feedback

Language Patterns for Ad Copy

Category	Language Patients Use	Language Patients Avoid
Condition	"hemorrhoids," "piles," "the problem down there"	Clinical terminology (prolapse, thrombosis)
Pain	"agony," "can't sit," "worst pain," "miserable"	"Discomfort" (understatement that dismisses)
Desired outcome	"normal again," "fixed," "gone for good," "back to life"	"Treatment modality," "intervention"
Fear	"scared of surgery," "afraid of the pain," "dreading it"	"Concerned about outcomes"
Search terms	"without surgery," "quick fix," "near me," "cost"	"Minimally invasive hemorrhoidopexy"

Copy Implication

Patients use simple, emotional language in search and conversation. Ad copy should mirror this: "back to work the same day" over "minimally invasive outpatient procedure." The published study provides the clinical credibility; the language should match the patient's vocabulary.

Top 10 Pain Points (Ranked by Frequency)

Rank	Pain Point	Frequency	Representative Quote
1	Pain during and after bowel movements	Very Common	"I'm afraid to go to the bathroom. The pain makes me avoid eating so I won't have to go."
2	Failed OTC treatments / recurring symptoms	Very Common	"I tried creams, ointments, cushions, sitz baths... nothing has really helped at all." — Reddit r/hemorrhoids
3	Embarrassment and stigma preventing treatment-seeking	Very Common	"I've been living with external hemorrhoids for 15 years. I always hid from people and never sought help." — Quora
4	Fear of surgical pain and recovery	Very Common	"I am terrified of the surgery. Everyone says the recovery is the worst pain of their life." — Patient.info
5	Impact on daily activities (sitting, working, exercising)	Very Common	"Sitting at a desk feels like torture, affecting focus and making simple tasks feel monumental." — USA Hemorrhoid Centers
6	Recurrence after treatment	Common	"I suffered a lot until I improved slightly, but about 2 months later, the disease recurred." — PMC qualitative study (Tavani et al., 2025)
7	Impact on intimate relationships and self-image	Common	"It bothers me, because I don't think that it is aesthetically pleasing." — ScienceDirect qualitative study
8	Confusion about treatment options / information overload	Common	"There are so many options — banding, surgery, laser, creams — I have no idea which one is actually right for me."
9	Cost and insurance uncertainty	Moderate	"Deciphering your personal benefits and insurance coverage can be a confusing and frustrating experience."
10	Psychological toll (anxiety, depression, isolation)	Moderate	"The constant pain and discomfort can take a severe emotional toll — frustration, irritability, and even depression." — Preparation H

Unmet Needs (Things Patients Want But Can't Find)

Unmet Need	Patient Language	Current Gap
A permanent fix that isn't major surgery	"I want something that gets rid of them for good without the horrible recovery"	Banding is low-pain but has 15-50% recurrence. Hemorrhoidectomy is permanent but has brutal recovery. Nothing threads the needle.
Same-day treatment with no/minimal recovery	"I can't take time off work for this"	Office procedures are limited to Grade I-II. Grade III patients face surgical recovery. No existing option offers same-day for Grade III.
Certainty it won't come back	"What's the point if they just come back in 6 months?"	Even surgical hemorrhoidectomy has ~5% recurrence. Patients want guarantees no treatment can honestly offer.
Honest recovery timelines from real patients	"Every clinic says 'minimal recovery' but the forums tell a different story"	Clinic marketing understates recovery; forums overstate it. No neutral source gives credible timelines.
Head-to-head procedure comparisons from a neutral source	"Every website is trying to sell me their specific procedure"	"Almost 50% of hemorrhoid treatment websites were of poor quality, and 63 of 144 were sponsored by herbal remedies." — PMC quality analysis
Long-term outcome data (5+ years)	"I want to know if people are still hemorrhoid-free 5 years later, not just 6 weeks"	FAST is the only minimally invasive procedure with published 5-year data. This directly fills the gap patients are asking for.
Transparent pricing before consultation	"I need to know what this will actually cost me before I commit"	Pricing varies $500-$15,000. Most clinics won't quote until consultation. Insurance coverage is opaque.

Emotional Spectrum

Stage	Dominant Emotions	Patient Language	FAST Messaging Match
Pre-treatment (suffering)	Fear, embarrassment, frustration, isolation, helplessness	"I've tried everything." "Nothing works." "I've been suffering in silence." "Too embarrassed to talk about it."	Normalize the condition. Acknowledge the suffering without minimizing it. "You're not alone — and there's something most doctors haven't told you about yet."
Decision point (researching)	Hope mixed with skepticism, cautious optimism	"Is this too good to be true?" "Has anyone actually tried this?" "Is it worth the money?" "What's the catch?"	Lead with published evidence, named physicians, specific numbers. Acknowledge skepticism directly: "We know this sounds too good to be true. Here's the data."
Post-treatment (relief)	Relief, regret for waiting, gratitude, evangelism	"I wish I'd done this years ago." "Life changing." "Best decision I ever made." "Don't wait like I did." "I finally feel normal again."	Capture this language for reviews and testimonials. "Don't wait like I did" is the single most powerful hook for converting patients in the suffering stage.

Trust Hierarchy (What Patients Trust When Evaluating Treatments)

Rank	Source	Trust Level	Why
1	Other patient experiences (forums, reviews)	Highest	Patients overwhelmingly seek peer validation first. Reddit and Patient.info threads are the first stop. They trust people who "have been through it" more than anyone.
2	Specialist doctor recommendation	High	Colorectal surgeon or GI recommendations carry strong weight, but only after the patient has already self-educated online. GPs trusted less for this condition.
3	Specific recovery timelines and outcomes	High	"Back to work in 2 days" and "no pain after day 3" are more persuasive than "minimal recovery." Patients want to know exactly what to expect.
4	Clinical studies / success rates	Moderate	Numbers like "92% pain-free" matter, but patients are skeptical of clinic-published stats. PubMed and Mayo Clinic carry more weight than clinic websites.
5	Online reviews (Google, Healthgrades)	Moderate	Star ratings and volume matter for choosing a specific provider. Patients are aware of fake reviews and sponsored content.
6	Clinic/procedure website	Low-Moderate	Patients read these but approach with skepticism. "Almost 50% of hemorrhoid treatment websites were of poor quality." — PMC
7	Social media ads / sponsored content	Low	High skepticism. "If it sounds too good to be true, it probably is" is a common refrain. Patients are especially wary of miracle-cure language.

Key Trust-Building Observations

Specificity builds trust: "92% pain-free in 248 patients, back to work same day" beats "quick and painless"
Acknowledging limitations builds trust: Patients distrust treatments that claim zero side effects or 100% success. Disclosing the 15.3% minor bleeding rate and 12.9% retreatment rate increases credibility.
Named, credentialed doctors build trust: Patients want to know who is performing the procedure — not just the clinic name
Transparency about cost builds trust: Hidden costs destroy credibility instantly. Listing the $3K-$5K range with financing options on the website removes a key conversion barrier.

What the Research Changed

10 findings that shifted the strategy from initial assumptions to evidence-backed positioning.

The Brand Is FAST, Not "Meribel Health"

Patients search for procedures (LASIK, Invisalign, Botox), not holding companies. FAST is the patient-facing identity; Meribel Health is the corporate credibility layer. All patient-facing marketing — ads, website, GBP, social — should lead with FAST.

So What: Brand confusion between FAST and Meribel Health will fragment search authority. Keep them separate.

TSH Competes With Patient Inaction, Not Surgeons

6.9M Americans with Grade II-III hemorrhoids are doing nothing. They have exited the decision entirely. The primary competitive barrier is not CRH or hemorrhoidectomy — it is the assumption that nothing between ointments and surgery exists.

So What: Messaging should lead with re-engagement: "there's a better option" — not procedure comparison.

THD Classified as Investigational — March 2025

THD's insurance reclassification removes a primary alternative from the minimally invasive tier. GI physicians who previously referred to THD now have nowhere to send Grade II-III patients.

So What: The minimally invasive position is now weaker than it's been in a decade. FAST arrives at exactly the right moment.

The Explainer Video Is a Liability

An existing video contains claims that are no longer legally permissible under FDA medical device advertising regulations. The risk extends to any materials that repeat those claims.

So What: Archive immediately with "DO NOT DISTRIBUTE." Every new creative asset must be independently substantiated against the published study.

The Journal Article Has a Data Discrepancy

The published study states "220 male and 128 female" (sums to 348, not 248). Only cite "248 patients" until clarified with the authors. Do not cite the gender split in patient-facing materials.

So What: Gareth should seek clarification from Dr. Sias or the journal directly before this undermines the evidence foundation.

The Physician Referral Channel Has Near-Zero Competition

THD's decline means GI physicians who encounter patients asking for minimally invasive options currently have no credible referral destination. This window is open now and will not remain open indefinitely.

So What: Gareth should personally meet the top 20 GI and colorectal practices within 30 miles before the clinic opens.

Seattle Launch Must Target September-November 2026

Demand follows two annual peaks: January-March and September-November. If the clinic opens summer 2026, the first revenue window is September. Missing it means waiting until January 2027.

So What: Reverse-engineer all timelines from September. Website by June. Google Ads by July. GBP by May. SEO content publishing now.

Cash-Pay Comparables Prove the Model

LASIK ($2K-$4K/eye), Sono Bello, Invisalign — all primarily cash-pay, serving millions of procedures annually. The target patient is comparing FAST to continued suffering, not price-shopping between procedures.

So What: The pricing conversation is about financing options, not about lowering the price.

Regulatory Trust Badges Are Available — If Verified

The Figma website design displays FDA, CE, and EU-MDR badges. If accurate, these are significant credibility signals. But displaying badges that overstate clearance is an FDA enforcement trigger.

So What: Confirm exact regulatory status with Gareth and legal counsel before the site goes live.

"The Surgery I Was Afraid Of" Is the Wrong Comparison Frame

Most patients are not choosing between FAST and hemorrhoidectomy. They already eliminated surgery. They're choosing between FAST and continued suffering for the next 5 years.

So What: Reframe the competitive set in every ad and landing page. The alternative to FAST is not surgery — it is continued suffering.

Bottom Line: Strategic Shifts

From initial assumptions to evidence-backed positioning

The research produced 8 strategic shifts that reframe how FAST should go to market:

Brand identity: Patient-facing brand is FAST, not Meribel Health. All patient marketing leads with the procedure brand.
Competitive frame: The real competitor is patient inaction (6.9M untreated), not other procedures. Messaging leads with "there's a better option" not "we're better than surgery."
Market timing: THD's investigational reclassification creates a physician referral vacancy. This window is time-limited — fill it before someone else does.
Evidence strategy: The published study (Sias & Milone 2025) is the single most valuable marketing asset. Every claim must trace to it. The explainer video with unsubstantiated claims is a liability, not an asset.
Launch sequencing: Infrastructure before spend. Website → GBP → CRM → Google Ads → physician outreach. Everything reverse-engineered from the September–November 2026 demand peak.
Pricing model: Cash-pay is the launch model, proven by LASIK/Sono Bello/Invisalign comparables. Not a limitation — a strategy. The pricing conversation is about financing, not discounting.
Channel priority: Physician referrals are highest quality (75% conversion, ~$75 PAC) and lowest cost. Gareth's personal outreach to 20 GI practices before clinic opening is the single highest-ROI pre-launch activity.
Data integrity: The journal article's gender count discrepancy (220+128=348 ≠ 248) must be resolved before patient-facing materials cite anything beyond "248 patients." Only cite the methods-section figure.

Act III

Personas & Positioning

Three patients. One brand. A positioning framework built on published evidence.

The Three Patients

Three distinct personas represent the reachable TAM. Each searches differently, fears differently, and converts differently.

ICP Priority Matrix

Persona	TAM %	Primary Channel	Entry Hook	Time to Decision	Retention Value
Marcus — "The Reluctant Avoider"	45%	Google Search (symptom-intent)	"Back to work the same day"	2-6 weeks	High — becomes quiet advocate
Sarah — "The Informed Advocate"	30%	SEO content / Study link	"Published 5-year outcomes"	1-3 weeks	Very High — shares research
Robert — "The Repeat Sufferer"	25%	Physician referral	"One session. Lasting results."	1-2 weeks	Highest — vocal advocate

Marcus

The Reluctant Avoider

Age42–55

GenderMale

GradeIII

HHI$80K–$150K

% of TAM45%

ChannelPaid Search

Snapshot: Marcus has been dealing with Grade III hemorrhoids for 2-5 years. He has tried every OTC remedy available. He has employer-sponsored insurance but would pay out-of-pocket to avoid a surgical hemorrhoidectomy. His primary fear is surgery pain and the 2-4 week recovery. He searches on his phone in private browsing mode late at night.

Core Fears

Surgery pain and 2-4 week recovery

Marcus has read hemorrhoidectomy recovery stories and decided he would rather live with the condition than face that. This fear is the primary driver of his 2-5 years of avoidance.

Embarrassment and disclosure

He hasn't told his spouse or doctor. He researches alone, late at night, in private browsing. Any marketing that feels public or social will lose him immediately.

Losing work time

As a professional, taking days off for a condition he hasn't disclosed is a nonstarter. Same-day recovery is a conversion-critical claim for this persona.

What Converts Marcus

"Back to work the same day" + 92% pain-free data + named physician credentials. These three proof points, in this order, move Marcus from avoidance to action. He needs to believe the procedure is real, safe, and fast enough to fit into a normal workday.

Marcus's Treatment Decision Cycle

Stage	Behavior	Duration	Reach Strategy
Avoidance	OTC products, ignoring symptoms	2-5 years	Not reachable — awaiting trigger
Pain spike	Late-night phone search, private browsing	Hours to days	Google Ads symptom-intent, SEO content
Research	Compares options, reads reviews	1-3 weeks	Retargeting, GBP reviews, comparison content
Validation	Checks physician credentials, study data	Days	Landing page with evidence, physician bios
Decision	Submits inquiry form (not phone call)	Same session or next visit	Low-friction form, "no call required" messaging
Post-procedure	Quiet satisfaction, tells 1-2 close friends	30+ days	Review capture, referral prompt

Marcus's Trust Hierarchy

Rank	Trust Signal
1	Specific outcome data (92% pain-free, 248 patients, 5-year follow-up)
2	Named physician credentials
3	Published journal article
4	Google reviews
5	Website clarity and clinical tone
6	Payment transparency
7	Friend recommendation

Sarah

The Informed Advocate

Age35–50

GenderFemale

GradeII–III

HHI$90K–$175K

% of TAM30%

ChannelSEO / Study Link

Attribute	Detail
Age	35-50
Gender	Female
Occupation	Health-conscious professional
Hemorrhoid Grade	Grade II-III
Context	First-time or post-pregnancy
HHI	$90K-$175K
Decision Style	Research-then-act

Snapshot: Sarah approaches her health decisions the way she approaches everything — with thorough research. She will read the actual Sias & Milone study, look up the physicians on PubMed, and evaluate the complication data before booking. Her motivation is finding the safest, most evidence-backed option available. Her conversion barrier is trust, not fear.

Core Fears

Incomplete or hidden data

Sarah will leave any site that makes vague claims without sourcing. She expects to see complication rates, not just success rates. Hiding the 15.3% minor bleeding rate would lose her trust permanently.

Unvetted physicians

She checks credentials. Physician bios without institutional affiliations, board certifications, and publication records are a red flag.

What Converts Sarah

Full published study linked + detailed physician bios + honest FAQ with complications (15.3% minor bleeding) + mention of Paris/NYC controlled trials. Sarah converts when she can verify every claim independently. She will become a vocal advocate who shares the research with others.

Sarah's Treatment Decision Cycle

Stage	Behavior	Duration	Reach Strategy
Discovery	Finds FAST through content or physician mention	Hours	SEO content, physician referral, study link
Deep research	Reads full study, checks physician backgrounds	1-5 days	Published study page, physician bios, FAQ
Verification	Cross-references claims, checks reviews	Days	Third-party reviews, Healthgrades profiles
Decision	Contacts clinic with specific clinical questions	Same week as verification	Detailed intake form, clinical consultation
Post-procedure	Shares research and outcome with network	Ongoing	Case study consent, referral program

Sarah's Trust Hierarchy

Rank	Trust Signal
1	Peer-reviewed article (Sias & Milone 2025)
2	Physician credentials and institutional affiliations
3	Specific complication data (15.3% minor bleeding, openly disclosed)
4	Planned trials information (Paris, NYC)
5	Patient reviews
6	Website clinical tone
7	Peer recommendations

Robert

The Repeat Sufferer

Age50–65

GenderMale

Prior TxBanding / Surgery

GradeIII (recurring)

% of TAM25%

ChannelPhysician Referral

25% of Reachable TAM

Robert has been through banding or surgery that didn't hold. He is the most valuable lead: high candidacy, high conversion, near-zero acquisition cost when physician-referred, and becomes a vocal advocate. He asks harder, more specific questions and has low patience for vague answers.

Attribute	Detail
Age	50-65
Gender	Male
Prior Treatment	Prior banding or surgery that didn't hold
Hemorrhoid Grade	Grade III recurring
Primary Need	One definitive solution with published 5-year durability
Decision Style	Low patience, asks harder/more specific questions

Snapshot: Robert has tried banding or surgery before — and it didn't last. He is done with half-measures. He needs published 5-year durability data and honest recurrence rates. He is the fastest converter when physician-referred (1-2 weeks) and the most valuable lead: high candidacy, high conversion, near-zero acquisition cost, and becomes a vocal advocate.

Core Fears

Recurrence — another treatment that doesn't last

Robert's defining experience is that previous treatments failed. He needs to see 5-year durability data, not 30-day follow-ups. The 87% asymptomatic at 5 years is the key data point.

Wasting time and money on another failed approach

He has already invested time, money, and hope in treatments that didn't work. He will not tolerate vague promises. Honest retreatment data (12.9%) builds the trust that converts him.

What Converts Robert

Honest recurrence data (87% at 5yr, 12.9% retreatment) + direct physician conversation + institutional credibility. Robert converts when a physician he trusts tells him the data is real. He is the fastest converter in the portfolio when physician-referred — 1-2 weeks from referral to procedure.

Robert's Treatment Decision Cycle

Stage	Behavior	Duration	Reach Strategy
Recurrence trigger	Symptoms return after prior treatment	—	Not directly reachable — physician channel
Physician visit	Tells GI doctor "it came back"	Days	Physician referral program
Validation	Researches FAST, focuses on durability data	Days	Landing page with 5-year outcomes, retreatment data
Decision	Calls clinic directly, asks specific clinical questions	1-2 weeks from referral	Phone consultation, physician-to-physician discussion
Post-procedure	Vocal advocate — tells friends, writes reviews	Ongoing	Review capture, case study consent, referral program

Robert's Trust Hierarchy

Rank	Trust Signal
1	5-year durability data (87% asymptomatic)
2	Honest recurrence rates (12.9% retreatment)
3	Physician directness (no evasion on tough questions)
4	Institutional affiliations
5	Published study (Sias & Milone 2025)
6	Other patient outcomes
7	Insurance/payment clarity

Brand Story & Voice

Brand archetype, tone, value proposition definitions, persona hooks, proprietary terms, and brand guardrails.

Brand Architecture

Brand Layer	Name	Audience	Purpose
Procedure Brand	FAST	Patients	Patient-facing identity — what people search for, book, and recommend
Corporate Brand	Meribel Health	Physicians, investors, press	Clinical credibility layer — institutional trust, regulatory compliance, corporate communications
Device Brand	Proprietary Anoscope	Physicians, regulators	IP protection layer — patent filings, physician-to-physician credibility, regulatory submissions

Brand Archetype: The Sage-Healer

Clinical authority paired with empathetic understanding. The FAST brand speaks with the confidence of published evidence and the sensitivity of a physician who understands patient embarrassment and fear. It never oversells, never dismisses, and never hides limitations.

Tone Framework: Medical Device Marketing

DO	DON'T
Lead with published data	Make absolute claims ("painless")
Use patient language ("back to normal")	Use clinical jargon ("thermal submucosal hemorrhoidopexy")
Acknowledge limitations honestly	Hide complication rates
Respect the embarrassment barrier	Use humor about the condition
Cite named physicians and institutions	Use anonymous testimonials

Evidence Hierarchy by Phase

Phase	Evidence Level	What It Means	Marketing Implications
Pre-launch (now)	Level IV — Case series	Single-center, 248 patients, 5-year follow-up (Sias & Milone 2025)	Can cite outcomes with attribution; must not imply RCT-level certainty
Post-trial (H2 2026+)	Level I/II — RCT	Paris and NYC controlled trials planned	Enables stronger comparative claims, insurance submission evidence
Mature (2027+)	Multiple studies	Multiple centers, larger N, replication	Full competitive positioning, physician adoption at scale

The Narrative Kernel

"For the millions who have been told their only option is living with it or enduring weeks of surgical recovery — there is now a 10-minute, evidence-backed alternative that most doctors haven't heard about yet."

Value Propositions

VP1: "There's a Better Option"

For: Patients who don't know TSH/FAST exists.

Problem: 6.9M Americans with Grade II–III hemorrhoids believe their only choices are OTC products that don't work or surgery they're terrified of. They've stopped looking.

Solution: Awareness that a 10-minute, evidence-backed procedure exists — backed by named physicians and published 5-year outcomes.

Benefit: Permission to act. The discovery that the gap between ointments and surgery has been filled.

VP2: "The Evidence Speaks"

For: Patients actively evaluating FAST.

Problem: Healthy skepticism about a new procedure. "Is this too good to be true?"

Solution: Published study (Sias & Milone 2025, 248 patients, 5-year follow-up), named physicians with institutional affiliations, honest complication rates (15.3% minor bleeding, 12.9% retreatment).

Benefit: Confidence to book. The data they need to trust that this is real.

VP1 Hooks by Persona

Persona	Hook 1 (Pain Spotlight)	Hook 2 (Credibility)	Hook 3 (Obstacle Flip)
Marcus	"You've been managing this for years. There's something your doctor hasn't mentioned."	"Between creams and surgery, there's a 10-minute option."	"Back to work the same day. No surgery. No stitches."
Sarah	"Published 5-year outcomes for 248 patients. The data you've been looking for."	"Built by physicians. Published in a peer-reviewed journal. Open-access."	"Read the study yourself. Then decide."
Robert	"Your banding sessions didn't last. This has 87% asymptomatic results at 5 years."	"One session. Published durability data. Named physicians."	"The option your GI doctor hasn't heard about yet."

VP2 Hooks by Persona

Persona	Hook 1 (Evidence)	Hook 2 (Specifics)	Hook 3 (CTA)
Marcus	"92% of 248 patients reported zero pain in 5 post-op days."	"10 minutes. Same-day recovery. Published in the Journal of Surgery."	"See if you're a candidate."
Sarah	"Sias & Milone 2025: 248 patients, 5-year follow-up, peer-reviewed, open-access."	"Complication rates disclosed: 15.3% minor bleeding, zero stenosis, zero incontinence."	"Read the research. Ask your questions. Decide with data."
Robert	"87% asymptomatic at 5 years. 12.9% needed a simple retreatment."	"Unlike banding, TSH addresses the anatomical cause — repositioning, not tissue removal."	"Talk to the physician. Get honest answers."

Proprietary Terms

Patient-facing procedure brand. The branded experience of Thermal Submucosal Hemorrhoidopexy (TSH). Used in all patient marketing, website, ads, GBP, and review platforms. Patients search for, book, and recommend "the FAST procedure."

TSH (Thermal Submucosal Hemorrhoidopexy)

Clinical name for the procedure. Used in physician communications, journal citations, referral packets, regulatory submissions, and investor materials. Never used in patient-facing marketing.

Brand Guardrails

Do

Lead with published data. Every claim traces to Sias & Milone 2025.
Use proper attribution. "In a published case series of 248 patients..."
Acknowledge limitations. 15.3% minor bleeding, 12.9% retreatment rate.
Respect embarrassment. Private, non-judgmental tone throughout.
Name physicians and institutions. Dr. Sias, Dr. Milone, Brooklyn Hospital Center.
Include disclaimers. "Individual results may vary" on all outcome claims.

Don't

Never use "painless" as absolute. Use "92% reported zero pain."
Never use the archived explainer video or claims derived from it.
Never cite the gender split (220 male / 128 female) until discrepancy resolved.
Never use humor about hemorrhoids — embarrassment is a real conversion barrier.
Never make FDA claims without legal verification of current clearance status.
Never use "guaranteed" or "permanent." Cite the 87% 5-year data instead.

Channel Roles

Channel	Role
Google Search	Primary acquisition. Symptom-intent + comparison queries. Evidence-first ad copy.
Google Business Profile	Local authority. Reviews, posts, booking. "Near me" capture. Zero cost, highest local impact.
Physician Referral	Highest-quality channel. Clinical credibility, published study, referral form. Gareth physician-to-physician.
SEO / Content	Long-term organic. Procedure education, symptom content, comparison pages. E-E-A-T compliance.
Email Nurture	Post-inquiry. 3-email evidence sequence. Fear reduction + scheduling CTA.
Meta (Facebook/Instagram)	Awareness only (Month 3+). Educational, outcome-framed. No health condition targeting.
Healthgrades / RealSelf	Third-party credibility. Physician profiles. Review platform presence.

Tagline Candidates — Patient-Facing FAST Brand

"Your hemorrhoid solution. 10 minutes."

Direct. Names the condition. Anchors on time. Works for search ads where clarity beats cleverness.

"Beyond ointments. Before surgery. FAST."

Positions FAST in the gap between the two options patients already know about. Introduces the brand name naturally.

"Same-day relief. Published results."

Pairs the emotional benefit (relief) with the rational differentiator (evidence). Works for physician-facing materials too.

"One visit. Real evidence. Your life back."

Three-beat rhythm. Covers the single-session advantage, clinical evidence, and patient outcome in 7 words.

"The procedure between living with it and surgery."

Directly addresses the category gap that defines the market opportunity. Most resonant for Marcus and Robert personas.

Positioning & Messaging

Narrative kernel, reframe ladder, messaging transformation, differentiation hierarchy, and complete language guide.

Narrative Kernel

"If FAST disappeared tomorrow, what would patients miss most?"

Not the technology. Not the device. Not the clinic. They would miss:

Knowing an option exists. Knowing there's something between ointments and surgery.
The end of the gap. No more "I guess I'll just live with it." No more avoiding the doctor.
Permission to act on a problem they've been hiding for years.

"For the millions who've been told their only option is living with hemorrhoids or enduring weeks of surgical recovery — there is now a 10-minute, evidence-backed alternative. FAST exists so patients can finally act on a solution they've been searching for, backed by real data from real physicians."

The Narrative Kernel

Kernel Test Across Personas

Marcus: "I finally don't have to choose between living with it and surgery." (Knowing = permission to act)

Sarah: "I finally found a procedure backed by real published data." (Knowing = evidence-based confidence)

Robert: "I finally found something with 5-year durability data." (Knowing = this one might actually last)

The kernel holds across all three. "Knowing an option exists" is the universal emotional outcome.

Reframe Ladder

FAST's category risk: if positioned as "another hemorrhoid treatment," the default comparison is banding (covered by insurance) or surgery (gold standard). The reframe moves the conversation to a problem only FAST solves.

The Obvious Problem

"Patients with hemorrhoids need better treatment options."

The Deeper Problem

The problem isn't treatment options. It's the gap. 6.9M Americans with Grade II–III hemorrhoids believe their only choices are OTC products that don't work or surgery they're terrified of. They've stopped looking.

Why Existing "Solutions" Fail

Banding (CRH): 3 sessions over 6 weeks, higher recurrence. THD: now "investigational" — insurance won't cover. Hemorrhoidectomy: 2–4 weeks severe pain — patients refuse. OTC: doesn't work for Grade II–III. Each fails on a different dimension patients care about.

The New Problem Only FAST Solves

"You've been told there's nothing between ointments and surgery. That hasn't been true since 2020." A published 10-minute procedure with 5-year outcomes data exists — and most doctors haven't heard about it yet. FAST doesn't offer another treatment. FAST fills the gap.

Core Positioning Statement

"For adults with Grade II–III internal hemorrhoids who have failed conservative treatment and fear surgical hemorrhoidectomy, FAST is the 10-minute minimally invasive procedure with near-zero pain and same-day recovery, backed by published 5-year outcomes for 248 patients."

B.A.D. to B.E.S.T. Messaging Transformation

Marcus: The Reluctant Avoider

B.A.D. (Current Risk)

"Minimally invasive hemorrhoid treatment with fast recovery."

Boastful: sounds like every clinic website
Abstract: "minimally invasive" means nothing to a scared patient
Dry: clinical, not empathetic — doesn't meet him where he is (2 AM, phone, private browsing)

B.E.S.T. Transformation

Benefit-led: "Back to work the same day. No surgery. No stitches."

Empathetic: "You've been avoiding this for years. We understand. Here's why this is different."

Story-driven: "He searched at 2 AM in private browsing. Three years of creams that stopped working. One Google search changed everything."

Transformational: "From 'I'll just live with it' to 'I went back to work the next day.'"

Final line: "You don't have to keep choosing between suffering and surgery."

Sarah: The Informed Advocate

B.A.D. (Current Risk)

"Evidence-based hemorrhoid treatment backed by clinical research."

Boastful: "evidence-based" is overused — every clinic claims this
Abstract: "clinical research" without specifics is meaningless
Dry: sounds like every medical website she's already dismissed

B.E.S.T. Transformation

Benefit-led: "248 patients. 5-year follow-up. Published and peer-reviewed. Read it yourself."

Empathetic: "You've been researching for weeks. Every site is selling something. Here's a published study you can evaluate on your own terms."

Story-driven: "She looked up the physicians on PubMed. She read the full study. She checked the complication rates. Then she called."

Transformational: "From 'I can't find data I trust' to 'I read the study and made my decision.'"

Final line: "The data you've been looking for exists. It's published, peer-reviewed, and open-access."

Robert: The Repeat Sufferer

B.A.D. (Current Risk)

"Long-lasting hemorrhoid treatment with proven durability."

Boastful: "proven" without specifics — he's heard this before from CRH
Abstract: how long is "long-lasting"? He needs a number.
Dry: doesn't acknowledge his history of treatments that failed

B.E.S.T. Transformation

Benefit-led: "87% asymptomatic at 5 years. If retreatment is needed, it's a simple localized procedure — not a full surgery."

Empathetic: "You've been through banding that didn't last. You've been through recovery you never want to repeat. This is different."

Story-driven: "Three banding sessions over two years. They always came back. Four months after FAST, he feels completely normal."

Transformational: "From 'every treatment fails eventually' to '87% asymptomatic at year five.'"

Final line: "You don't need another temporary fix. You need durability data you can trust."

Differentiator Hierarchy

Rank	Differentiator	Defensibility	Patient Impact	Evidence Source
1	10-minute procedure, same-day recovery	High	Highest	Published
2	92% zero pain in 5 post-op days	High	Highest	Published
3	Zero stenosis, incontinence, and infection	High	High	Published
4	87% asymptomatic at 5 years	Medium (single center)	High	Published
5	Anatomical restoration vs tissue removal	High (mechanism)	Medium	Published
6	Patented anoscope device	High (IP)	Low (patient-facing)	Patent filings
7	Owned-clinic experience control	High (operational)	Medium	Strategic

Messaging by Persona

Persona	Primary Hook	Proof Point	CTA	Tone
Marcus	"Back to work the same day. No surgery."	92% pain-free, 10 min, 248 patients	"See if you're a candidate"	Direct, empathetic, private
Sarah	"Published 5-year outcomes. Real data."	248 patients, Sias & Milone 2025, open-access	"Read the research"	Clinical, thorough, evidence-respectful
Robert	"One session. Lasting results."	87% asymptomatic at 5 years	"Talk to a physician"	Direct, honest, no overselling

Messaging by Channel

Channel	Audience	Message Emphasis	Format	Guardrail
Google Search (symptom-intent)	Marcus, Sarah	Pain-free, same-day, 10-minute	Responsive search ad	No absolute claims; cite study
Google Search (comparison)	Sarah, Robert	Single session vs 3 bandings, published data	Responsive search ad	Fair balance on comparison claims
Google Business Profile	All (local)	Seattle clinic, reviews, physician credentials	GBP posts, Q&A	HIPAA: no patient names without consent
Physician referral	Robert	Published outcomes, mechanism of action, physician-to-physician	Leave-behind, study reprint	Clinical language appropriate for physician audience
Email nurture	Marcus, Sarah	Evidence progression: study → physician → FAQ → financing	3-email sequence	CAN-SPAM compliance, easy unsubscribe
Meta awareness	Marcus, Sarah	Category education — "between ointments and surgery"	Static/video carousel	No health condition targeting; educational framing only

Tagline Candidates

"Beyond ointments. Before surgery. FAST."

Universal — Primary recommendation

Positions FAST in the gap. Names the brand. Category-creating.

"Your hemorrhoid solution. 10 minutes."

Marcus — Best for search ads

"Same-day relief. Published results."

Sarah — Best for evidence-first contexts

"One visit. Real evidence. Your life back."

Robert — Best for durability positioning

"The procedure between living with it and surgery."

Universal — Best for category creation

"Published data. Named physicians. Real results."

Sarah — Best for trust-building contexts

Category Creation Language

Do Say

"The 10-minute hemorrhoid procedure"
"Evidence-backed hemorrhoid treatment"
"Published outcomes for Grade II–III hemorrhoids"
"Same-day recovery hemorrhoid solution"
"The procedure between ointments and surgery"

Don't Say

"Hemorrhoid cure" (no cure exists — cite 87% 5-year data)
"Painless procedure" (absolute claim — use "92% reported zero pain")
"Alternative medicine" (FAST is evidence-based, not alternative)
"Hemorrhoid removal" (mechanism is repositioning, not removal)
"Revolutionary" / "breakthrough" (vague superlatives that trigger skepticism)

Act IV

Funnel & Channels

From impression to procedure — the full acquisition architecture.

Full Funnel Architecture

Two primary funnels — Google Ads/SEO and physician referral — with unit economics for each.

Google Ads + SEO Funnel (Month 6 Target — Seattle Geo)

Stage	Monthly Volume	Conversion Rate	Notes
Impressions	60,000-80,000	—	Symptom-intent + comparison keywords
Clicks	900-1,200	1.5% CTR	Medical procedure average
Leads	117-156	13% CVR	Target landing page conversion
Booked consultations	70-109	60-70%	Same-day callback drives rate
Clinical candidates	56-87	80% candidacy	Grade II-III confirmed
Procedures scheduled	25-48	45% decision	Cash-pay friction is primary variable
Procedures completed	24-46	95% show rate	Confirmation sequence
Monthly revenue	$96K-$184K	—	At $4,000/procedure

Physician Referral Funnel (Month 6 Target)

Stage	Monthly Volume	Rate	Notes
Active referring physicians	5-7	—	Target: 10 by Month 12
Referrals per physician/month	2-4	—	Standard GI volume
Monthly referral leads	10-28	—	Pre-qualified, high intent
Consultations completed	9-25	90%+	Physician-referred show rate
Procedures completed	7-19	75%	Higher conversion than paid
PAC (physician channel)	~$75	—	Relationship cost amortized

Unit Economics Scenarios

Scenario	CPL	Consult Rate	Procedure Rate	PAC	LTV:PAC
Conservative (launch)	$150	40%	45%	$833	4.8:1
Base (Month 6)	$120	50%	50%	$480	8.3:1
Optimized (Month 12)	$100	55%	55%	$331	12.1:1
Physician referral	~$50	85%	75%	~$78	51:1

Visual: Google Ads Patient Funnel

Impressions: 60,000–80,000/mo

Clicks: 900–1,200 (1.5% CTR)

Leads: 117–156 (13% CVR)

Consultations: 70–109 (60–70%)

Clinical Candidates: 56–87 (80%)

Procedures: 24–46
$96K–$184K/mo revenue

Persona-Specific Funnel Paths

Persona	Entry Point	Primary Channel	Avg Time to Decision	Consult→Procedure Rate	Key Conversion Trigger
Marcus	Symptom search at 2 AM	Google Search (symptom-intent)	2-6 weeks	45%	"Back to work same day" + 92% pain-free data
Sarah	Research-mode comparison	SEO content / Study link	1-3 weeks	55%	Published study + named physician credentials
Robert	Physician referral	GI doctor recommendation	1-2 weeks	75%	5-year durability data + honest recurrence rates

Funnel Optimization Levers

Landing Page CVR: 13% → 15%

A 2-point CVR improvement yields +15% more leads from the same ad spend. Test headline variants, CTA placement, and proof point emphasis. The single highest-leverage optimization in the paid funnel.

Impact: +18-23 additional leads/month at zero incremental ad cost.

Consult Booking Rate: 60% → 70%

Same-day callback is the primary driver. Moving from 60% to 70% booking rate means 17% more consultations from the same lead volume. Speed-to-contact and the quality of the first phone interaction are the levers.

Impact: +12-16 additional consultations/month from existing leads.

Cash-Pay Conversion: 45% → 55%

Price transparency, financing options (CareCredit/Affirm), and transparent complication disclosure during consultation reduce decision friction. A 10-point improvement yields 22% more procedures from the same consultations.

Impact: +12-19 additional procedures/month from existing consultations.

Physician Referral Activation: 0 → 7 Physicians

Each active referring physician generates 2-4 referrals/month at 75% conversion and ~$75 PAC. Seven active physicians = 10-28 referrals/month = 7-19 incremental procedures at near-zero patient acquisition cost.

Impact: +7-19 incremental procedures/month at ~$75 PAC vs. $480 paid PAC.

Key Takeaway

The physician referral channel delivers 51:1 LTV:PAC — more than 10x the paid channel. Every dollar invested in physician relationships returns disproportionately. However, paid search provides the volume; physician referrals provide the margin. Both channels are required.

Channel Strategy

Three tiers — build before Day 1, start early to compound, and post-launch optimization.

Tier 1 — Build Before Day 1

Google Search (Seattle Geo)

$5K-$10K/month. Symptom-intent queries ("hemorrhoid treatment without surgery") and comparison queries ("hemorrhoid banding vs alternatives"). Target CPL $120-$150 at launch. Seattle DMA geo-targeting only. This is the primary volume driver for the first 6 months.

Why Tier 1: Captures existing demand from patients actively searching. Without this, the website has no traffic and every other channel has no conversion endpoint.

Google Business Profile

Zero cost. Critical for "near me" queries, which represent a significant share of local medical searches. 1-2 posts/week, review capture automation from Day 1. Target: 20+ reviews by Month 6 with 4.5+ rating.

Why Tier 1: GBP is the first thing patients see for local medical searches. No GBP listing means invisible to "hemorrhoid doctor near me Seattle."

Physician Referral Program

Target top 50 GI and colorectal practices within 30 miles of the Seattle clinic. Gareth personal outreach with referral packet including the published study, physician credentials, and patient pathway. 5-7 active referring physicians by Month 6.

Why Tier 1: 75%+ consultation-to-procedure conversion at ~$75 PAC. THD's decline creates a referral vacancy that won't stay open.

Tier 2 — Start Early, Compound Over Time

SEO & Content

5 foundational pages at launch (procedure overview, clinical evidence, physician bios, FAQ, contact). 2 blog posts/month targeting symptom and comparison queries. E-E-A-T compliance with named physician authorship. Schema markup for medical procedure, physician, and FAQ structured data.

Why Tier 2: SEO compounds — content published now ranks by Month 4-6. Starting late means waiting even longer for organic traffic.

Meta Awareness (Month 3+)

$2K-$5K/month. Seattle geo, ages 35-65. Educational and outcome-framed creative — no health condition targeting (Meta policy). Carousel and short-form video formats. Primary purpose: build awareness for the category gap ("between ointments and surgery").

Why Tier 2: Meta creates demand awareness but doesn't capture intent. Effective only after the search + GBP infrastructure converts the awareness into consultations.

Tier 3 — Post-Launch Optimization

Retargeting (Month 2+)

30-90 day retargeting window for website visitors who didn't convert. Evidence card rotation (rotating proof points across touchpoints). HIPAA pixel disclosure required on all retargeting-enabled pages.

Why Tier 3: Requires sufficient website traffic volume to build retargeting audiences. Premature launch wastes budget on thin audiences.

KOL / Influencer (Month 4+)

Medical professional KOLs are the primary tier — physician-to-physician credibility. Health and wellness creators are secondary — patient awareness for Marcus and Sarah personas. FTC compliance is mandatory for all paid relationships.

Why Tier 3: Influencer content is most effective when the website, reviews, and conversion infrastructure already exist to capture the interest it generates.

Channel Budget Summary (Month 6 Target)

Channel	Monthly Budget	Primary Metric	Target
Google Search	$5K-$10K	CPL	$120-$150
Google Business Profile	$0	Reviews	20+ by Month 6
Physician Referral	Variable (time + materials)	Active referring MDs	5-7
SEO & Content	Included in ops	Organic sessions	500+/month by Month 6
Meta Awareness	$2K-$5K	Awareness reach	Seattle 35-65 audience
Retargeting	$500-$1K	Return visitor CVR	Incremental conversions
Total	$7.5K-$16K/month

Not Recommended (Current Stage)

TV/Radio: Too broad, too expensive, no attribution. Wait for multi-clinic scale.
Print/Direct Mail: Low targeting precision for a geo-specific medical procedure. CPL will be 3-5x digital.
TikTok: Platform demographics skew young (18-34). FAST's ICP is 35-65. Revisit when audience data warrants.
Programmatic Display: Low intent, high impression waste. Use retargeting (specific audiences) instead of broad display.
PR/Media: No earned media strategy until first patient outcomes can be shared. Premature publicity without proof harms credibility.

Per-Persona Channel Recommendations

Persona	Primary	Secondary	Avoid
Marcus	Google Search (symptom-intent)	Meta awareness, retargeting	Phone-based outreach (he won't pick up)
Sarah	SEO content, Google Search (comparison)	Email nurture with study link	Vague awareness ads without data
Robert	Physician referral	Branded Google Search	Broad awareness — he already knows he needs treatment

Phased Channel Rollout

Phase	Channels Active	Monthly Budget	Expected Leads	Expected Procedures
Month 1-2	Website + GBP + Physician outreach	$0 (infrastructure)	5-15 (organic + referral)	3-8
Month 2-3	+ Google Ads	$5K-$10K	30-60	12-25
Month 3-4	+ Email nurture + Retargeting	$6K-$11K	50-90	20-40
Month 4-6	+ Meta awareness + KOL pilot	$8K-$16K	80-140	35-65
Month 6-12	All channels optimized	$10K-$20K	120-200	50-90

Channel Synergies & Dependencies

Google Ads + GBP

Patients who see an ad then check GBP reviews convert at 2-3x the rate of ad-only. GBP review velocity directly improves paid search ROI.

Dependency: GBP must be claimed and actively collecting reviews before scaling Google Ads spend.

SEO + Google Ads

Organic rankings reduce CPL by providing free clicks for queries currently only covered by paid. Every organic ranking replaces paid click cost.

Dependency: SEO content must be published early so it begins ranking by the time paid spend scales.

Physician Referral + Website

Referred patients validate their referral by checking the website. A weak website undermines the physician's recommendation.

Dependency: Website must be live with physician bios, published study link, and FAQ before physician outreach begins.

Meta Awareness + Google Search

Meta creates problem awareness; Google captures the resulting search intent. Without search capture, awareness spend has no conversion path.

Dependency: Google Ads must be running and optimized before launching Meta awareness campaigns.

Act V

The Creative

Hooks, ad concepts, and a KOL program designed around published evidence.

Hook Library

20 hooks organized by type — each mapped to persona, channel, and evidence source.

PAS Hooks (Problem-Agitate-Solve)

"When ointments stop working, most patients give up. Here's what they don't know."

Targets the OTC-failure moment — the #2 search intent theme. Agitates the assumption that ointments are the final option before surgery.

Persona: Marcus | Channel: Google Search, Meta awareness

"You've been managing hemorrhoids for years. The creams help less and less. There's something your doctor probably hasn't mentioned."

Mirrors Marcus's lived experience — years of declining OTC effectiveness. Introduces the idea of a physician-validated alternative.

Persona: Marcus | Channel: Meta awareness, SEO content

"Three banding sessions. Six weeks. And they came back. Sound familiar?"

Directly addresses Robert's experience with failed banding. Agitates the recurrence frustration that defines his persona.

Persona: Robert | Channel: Google Search (comparison), retargeting

"You've Googled 'hemorrhoid treatment without surgery' at 2 AM. Here's the answer you've been looking for."

Mirrors Marcus's actual search behavior — private, late-night, phone-based. Creates an immediate sense of recognition and relevance.

Persona: Marcus | Channel: Google Search (symptom-intent)

Evidence-Led Hooks

"92% of patients reported zero pain in the 5 days after the procedure."

Lead proof point from published study (Sias & Milone 2025). The single most powerful clinical claim available. Must always include study attribution.

Persona: All | Channel: Google Search, landing page, Meta

"87% of patients were completely asymptomatic at their 5-year follow-up."

Long-term durability claim — the key data point for Robert and the primary differentiator against banding recurrence rates.

Persona: Robert, Sarah | Channel: Google Search (comparison), physician referral

"248 patients. Published outcomes. Named physicians. Real data."

Stacks credibility signals in a single line. Works for Sarah's evidence-first decision style and Robert's low tolerance for vague claims.

Persona: Sarah, Robert | Channel: Google Search, landing page

"10 minutes. One session. Published 5-year results."

Compressed format — three differentiators in seven words. Optimal for ad headlines and GBP post titles where space is limited.

Persona: All | Channel: Google Search headlines, GBP posts

Persona Callout Hooks

"I was out of work for 3 weeks after hemorrhoid surgery. I wish I'd known there was another way."

Mirrors Marcus's fear of surgery recovery and work disruption. First-person framing for testimonial-style ads (requires consented patient or representative persona disclosure).

Persona: Marcus | Channel: Meta awareness, retargeting

"10 minutes. The doctor used a specialized device. I went back to work the next day."

Outcome-focused first-person hook. Covers procedure time, device mention (credibility), and same-day recovery in one statement.

Persona: Marcus | Channel: Meta awareness, video script

"I read the actual study before I booked. The data convinced me."

Directly targets Sarah's decision style — research-first, evidence-driven. Validates her approach and positions FAST as the option that rewards investigation.

Persona: Sarah | Channel: Meta awareness, SEO content

"Hemorrhoid banding requires 3 appointments over 6 weeks. This takes 10 minutes, once."

Direct comparison against CRH banding — the primary procedural competitor. Factual, verifiable, and resonant for Robert who has experienced the multi-session burden.

Persona: Robert | Channel: Google Search (comparison), landing page

Contrarian Hooks

"The surgery you're afraid of isn't your only option. It's not even a good one."

Reframes the surgery-fear narrative. Instead of positioning FAST as "better than surgery," it challenges the assumption that surgery is the standard of care for Grade II-III.

Persona: Marcus | Channel: Meta awareness, SEO content

"Between ointments and surgery, there's a 10-minute option most doctors don't know about yet."

Defines the category gap and positions FAST as the missing middle. "Most doctors don't know" creates urgency and explains why patients haven't heard of it.

Persona: Marcus, Sarah | Channel: Meta awareness, Google Search

"Your hemorrhoids aren't getting better because creams don't fix Grade II-III disease."

Clinical truth delivered in patient language. Names the grade classification to educate while disrupting the OTC comfort zone.

Persona: Marcus | Channel: SEO content, Meta awareness

Curiosity Gap Hooks

"A published study followed 248 patients for 5 years. Here's what happened."

Opens a curiosity gap with the study's scale and duration. Works for Sarah who will click through to read the actual data.

Persona: Sarah | Channel: Meta awareness, SEO content, email nurture

"Why 6.9 million Americans with hemorrhoids are suffering unnecessarily."

Scale-based curiosity gap. The 6.9M figure grounds the claim in published data while inviting the reader to learn why their suffering is optional.

Persona: Marcus, Sarah | Channel: SEO content, Meta awareness

"The procedure that changes the conversation about hemorrhoid treatment."

Category-level framing. Positions FAST as not just an option but a paradigm shift. Works for physician-facing content and high-level awareness.

Persona: Sarah, physicians | Channel: SEO content, physician outreach

Privacy / Trust Hooks

"We respond to inquiries in English, French, or Italian. Your privacy matters."

Addresses the embarrassment barrier while signaling the international clinical heritage (Paris, Naples). Multilingual capability differentiates from US-only competitors.

Persona: Marcus | Channel: Website, email nurture

"No phone call required. Start with a private online consultation request."

Removes the phone-call barrier that Marcus dreads. Digital-first intake respects his privacy and matches his late-night, private-browsing research behavior.

Persona: Marcus | Channel: Landing page CTA, Google Search sitelink

Ad Concepts

Four Google Ads campaigns and four Meta concepts — each mapped to a persona and funnel stage.

Google Ads Campaigns

Campaign	Headline 1	Headline 2	Headline 3	Description
Treatment-intent	Hemorrhoid Treatment Seattle	10-Minute Procedure, Same Day	Published 5-Year Outcomes	Near-zero pain. Back to work same or next day. Learn if you're a candidate for the FAST procedure.
Comparison	Not Ready for Surgery?	Grade III Hemorrhoid Alternative	One Visit. Lasting Results.	92% of 248 patients reported zero pain. Published results. Board-certified physicians.
Symptom-intent	Hemorrhoids Won't Go Away?	Creams Stopped Working?	Modern Treatment Option	A 10-minute minimally invasive option. Published 5-year outcomes for 248 patients. Seattle clinic.
Physician-referred	Referred by Your Doctor?	The FAST Procedure — Seattle	Peer-Reviewed Outcomes	Your physician referred you here. Learn what to expect and see published data for 248 patients.

Meta Ads Concepts

Concept	Format	Hook	Targeting	Guardrail
"The Gap" awareness	Static carousel	"Between ointments and surgery, there's a 10-minute option."	Seattle 35-65, health/wellness	No health condition targeting
Physician story	Video 30s	Named physician explains approach to common condition	Lookalike from consult visitors	Must disclose paid relationship
Outcome education	Single image	"92% zero pain" with study citation visible	Seattle 35-65, health interest	Cite Sias & Milone 2025 visibly
FAQ-format	Short-form 60s	"3 questions patients ask before their first FAST appointment"	Retargeting non-converters	No diagnosis advice

Creative Compliance Guardrails

No absolute claims ("painless," "guaranteed," "100%"). Use "near-zero pain" or "92% reported zero pain."
Every clinical claim must cite Sias & Milone 2025 or the specific data source.
No before/after imagery without explicit patient consent and HIPAA compliance.
Meta: no health condition targeting. Use interest/behavioral targeting only.
FTC: all paid relationships (KOL, influencer) must be disclosed.
FDA: no off-label claims; stay within cleared indications.

Messaging Matrix

Message Type	Persona	Funnel Stage	Channel	Format	Key Copy Element
Fear-of-surgery intercept	Marcus	TOF Awareness	Meta, Google	Static, RSA	"No surgery. No stitches. Back to work same day."
OTC-failure trigger	Marcus	MOF Research	Google Search	RSA	"When creams stop working, there's a 10-minute option."
Evidence-first education	Sarah	MOF Research	Google, SEO	Long-form, RSA	"248 patients. 5-year follow-up. Published and peer-reviewed."
Comparison positioning	Sarah, Robert	MOF Evaluation	Google Search	RSA	"Banding: 3 sessions over 6 weeks. FAST: 10 minutes, once."
Durability proof	Robert	BOF Decision	Google, Email	RSA, Email	"87% asymptomatic at 5 years."
Privacy-first CTA	Marcus	BOF Decision	Landing page	CTA button	"No phone call required. Start with a private online request."
Physician-referred validation	Robert	BOF Decision	Landing page	Dedicated LP	"Your physician referred you here. Here's what to expect."
Post-procedure advocacy	All	Post-procedure	Email, Text	Automated	"How was your experience? Leave a review."

Cross-Persona Sequential Funnel

Persona	Touch 1 (Awareness)	Touch 2 (Consideration)	Touch 3 (Decision)
Marcus	Meta: "Between ointments and surgery, there's a 10-minute option"	Google Search: "Hemorrhoid Treatment Seattle — 10 Min, Same Day"	Retargeting: "92% of 248 patients reported zero pain. See if you qualify."
Sarah	SEO: "Hemorrhoid Treatment Options Compared: Banding vs TSH vs Surgery"	Google Search: "Published 5-Year Hemorrhoid Outcomes — Sias & Milone 2025"	Email: "Read the full study. Then decide."
Robert	Physician referral: GI doctor mentions FAST during visit	Website: Dedicated physician-referral landing page with study data	Email nurture: "Your consultation is confirmed. Here's what to expect."

Story System — Full RSA Ad Copy

Treatment-Intent Campaign

Headlines (15)

H1: Hemorrhoid Treatment Seattle
H2: 10-Minute Procedure — Same Day
H3: Published 5-Year Outcomes
H4: No Surgery Required
H5: Back to Work Same Day
H6: FAST Procedure Seattle
H7: Board-Certified Physicians
H8: 92% Reported Zero Pain
H9: One Visit — Lasting Results
H10: Free Consultation Available
H11: Minimally Invasive Treatment
H12: Grade II-III Hemorrhoid Solution
H13: 248 Patients Studied
H14: Seattle's FAST Procedure Clinic
H15: Same-Day Recovery

Descriptions (4)

D1: Near-zero pain. Back to work same or next day. Learn if you're a candidate for the FAST procedure in Seattle.
D2: Published 5-year outcomes for 248 patients. Board-certified physicians. Book your consultation today.
D3: A 10-minute outpatient procedure backed by peer-reviewed clinical data. Seattle's only FAST procedure clinic.
D4: Grade II-III hemorrhoid treatment without surgery. Published results. Same-day recovery. Schedule now.

Comparison Campaign

Headlines (15)

H1: Not Ready for Surgery?
H2: Grade III Hemorrhoid Alternative
H3: One Visit. Lasting Results.
H4: Banding Failed? There's an Option
H5: FAST vs Hemorrhoid Banding
H6: Skip the 3-Session Banding
H7: 87% Asymptomatic at 5 Years
H8: 10 Minutes vs 6 Weeks
H9: Published Comparison Data
H10: Better Than Banding — Published Proof
H11: One Procedure, Not Three
H12: 12.9% Retreatment Rate
H13: Hemorrhoid Treatment Comparison
H14: Beyond Banding & Surgery
H15: See the Published Results

Descriptions (4)

D1: 92% of 248 patients reported zero pain. Published results. Board-certified physicians. Compare your options.
D2: Banding requires 3 sessions over 6 weeks. FAST takes 10 minutes, once. See the published 5-year outcomes.
D3: 87% of patients were asymptomatic at their 5-year follow-up. One visit. No general anesthesia. Seattle clinic.
D4: Tired of treatments that don't last? Published 5-year data shows lasting results. Book a consultation.

Symptom-Intent Campaign

Headlines (15)

H1: Hemorrhoids Won't Go Away?
H2: Creams Stopped Working?
H3: Modern Treatment Option
H4: Bleeding Hemorrhoid Treatment
H5: End the Cycle of OTC Creams
H6: 10-Minute Outpatient Procedure
H7: No Surgery. No Stitches.
H8: Hemorrhoid Pain Relief — Seattle
H9: When Home Remedies Fail
H10: A Real Fix, Not Another Cream
H11: Walk In, Walk Out Same Day
H12: Clinically Proven Treatment
H13: 92% Zero Pain After Procedure
H14: Private Online Consultation
H15: Stop Managing, Start Solving

Descriptions (4)

D1: A 10-minute minimally invasive option. Published 5-year outcomes for 248 patients. Seattle clinic.
D2: When OTC creams stop working, there's a step between ointments and surgery. Learn about the FAST procedure.
D3: No phone call required. Start with a private online request. Published outcomes. Board-certified physicians.
D4: 92% of patients reported zero pain. Back to work same day. See if you qualify for the FAST procedure.

Physician-Referred Campaign

Headlines (15)

H1: Referred by Your Doctor?
H2: The FAST Procedure — Seattle
H3: Peer-Reviewed Outcomes
H4: Your Doctor Recommended FAST
H5: What to Expect — FAST Procedure
H6: Physician-Referred Patients
H7: Published 5-Year Follow-Up
H8: Board-Certified Specialists
H9: Consultation Next Steps
H10: Trusted by GI Physicians
H11: 248 Patients, Published Data
H12: Your Referral, Our Expertise
H13: 87% Asymptomatic at 5 Years
H14: Schedule Your Consultation
H15: Evidence Your Doctor Trusts

Descriptions (4)

D1: Your physician referred you here. Learn what to expect and see published data for 248 patients.
D2: The FAST procedure your doctor recommended: 10 minutes, local anesthesia, published 5-year outcomes.
D3: Board-certified physicians performing the procedure your GI doctor trusts. Schedule your consultation.
D4: 87% asymptomatic at 5 years. 92% zero pain. See why your physician recommends the FAST procedure.

KOL & Patient Advocacy Program

A three-tier influence program built on clinical credibility, patient stories, and regulatory compliance.

Program Overview

The KOL and patient advocacy program operates on two tracks: a medical KOL program for physician-to-physician credibility and a patient advocacy program for real-world outcome stories. Both are governed by HIPAA and FTC compliance frameworks. The goal is earned credibility — not paid endorsement theater.

KOL Tiers

Tier	Who	Role	Content Type	Compliance
Tier 1: Medical KOLs	GI physicians, colorectal surgeons with social or academic presence	Physician-to-physician credibility	Case discussions, conference presentations, study commentary	Full disclosure of any financial relationship
Tier 2: Health/Wellness Creators	Health and wellness content creators with engaged audiences	Patient awareness for Marcus and Sarah personas	Educational content about hemorrhoid treatment options, procedure explainers	FTC paid partnership disclosure, no diagnosis advice
Tier 3: Patient Advocates	Post-procedure patients who consent to share their stories	Social proof and peer-to-peer trust	Written testimonials, video stories, review site advocacy	HIPAA consent, voluntary participation, no compensation for content

Content Pillars

Clinical Evidence Education

KOLs discuss published outcomes, study methodology, and clinical significance. Content anchored to Sias & Milone 2025 and planned Paris/NYC trials. Target audience: physicians and evidence-seeking patients (Sarah).

Patient Experience Stories

Consented patients share their journey — from years of OTC management to the procedure and recovery. Authenticity is the differentiator; scripted testimonials destroy trust. Target audience: Marcus, Robert.

Procedure Myth-Busting

Address common misconceptions: "all hemorrhoid treatments hurt," "surgery is the only real fix," "new procedures are experimental." Physicians and patients co-create content that dismantles fear-based assumptions.

Physician Commentary

Named physicians discuss the mechanism of action, patient selection criteria, and clinical decision-making. This content serves dual purposes: physician education for referrals and patient trust-building.

HIPAA / FTC Compliance Framework

Mandatory Requirements

HIPAA: Written patient consent (HIPAA authorization form) before any patient story is published, including de-identified stories
HIPAA: No identifiable patient information without explicit, signed release
FTC: All paid relationships must be disclosed — "paid partnership," "sponsored," or equivalent
FTC: Influencer claims must be substantiated — no outcomes that exceed the published data
FDA: No off-label promotion; all claims must stay within cleared indications
State: Washington State medical advertising regulations compliance review before publishing
Internal: All influencer content reviewed against guardrails before publishing — no exceptions

Content Approval Workflow

Step	Action	Owner
1	KOL/influencer drafts content based on approved talking points	Creator
2	Marketing reviews against brand voice and messaging guardrails	Marketing
3	Clinical review verifies all claims are substantiated by published data	Medical/Clinical
4	Legal/compliance confirms FTC, HIPAA, and FDA adherence	Legal
5	Final approval and publish authorization	Marketing + Clinical

Act VI

Operations

From inquiry to post-procedure advocacy — the activation playbook, timeline, and measurement framework.

Activation Playbook

The patient journey from first inquiry through post-procedure advocacy — every touchpoint mapped.

Patient Journey Map

First Touch

Google search / Meta ad / Physician referral
Patient discovers FAST exists. Visits website. Spends 2-5 minutes on procedure page and FAQ.

Inquiry

Online form submission (preferred) or phone call
Patient submits consultation request. Receives immediate confirmation email (Email 1). CRM creates lead record. Same-day callback from clinic.

Nurture

3-email evidence sequence over 7 days
Day 0: Confirmation + physician bio. Day 3: Clinical evidence + FAQ. Day 7: Financing options + scheduling CTA. For non-responders: Day 14 re-engagement email.

Consultation

In-person clinical evaluation
Physician confirms Grade II-III candidacy (80% of inquiries qualify). Discusses procedure, expected outcomes, and honest complication rates. Addresses specific patient fears. Provides financing options if needed.

Procedure

10-minute outpatient session
Local anesthesia. Proprietary anoscope. Patient walks out same day. Digital post-procedure instructions delivered immediately via email and text.

Recovery & Follow-Up

Day 1-30 activation sequence
Day 1: Text check-in. Day 7: Satisfaction survey + Google review request. Day 30: Outcome survey + referral ask. Day 90: Long-term follow-up + case study consent.

Advocacy

Patient becomes acquisition channel
Google review published. Referral to 1-2 friends/colleagues. Case study consent for marketing use. The patient who arrived through Google Ads now generates zero-cost referrals.

Pre-Consultation Email Sequence

Email 1 — Immediate: "Your FAST consultation is confirmed"

Sent immediately upon inquiry submission. Contains: what to expect during the consultation, physician bio and credentials, link to FAQ page, and a direct phone number for questions. Tone: warm, professional, reassuring. This email sets the clinical credibility tone for the entire patient relationship.

Email 2 — Day 3: "What the research shows"

Delivers the key study findings: 248 patients, 92% zero pain, 87% asymptomatic at 5 years. Addresses common fears directly (pain, recovery time, complications). Links to the published study for patients who want to read the full data. Tone: educational, evidence-first.

Email 3 — Day 7: "Ready to take the next step?"

Covers financing options (CareCredit, payment plans). Includes "patients like you" social proof (when consented testimonials are available). Direct scheduling link with available times. Tone: supportive, no pressure, clear next action.

Day-of-Procedure

Patient Experience

Arrival: Welcoming environment, minimal paperwork (pre-filled digitally), physician introduction
Procedure: 10-minute session, local anesthesia, proprietary anoscope device
Post-procedure: Instructions delivered digitally (email + text), physician contact info for questions, expected recovery timeline
Departure: Same-day — patient walks out and returns to normal activity

Post-Procedure Activation

Timing	Touchpoint	Purpose	Channel
Day 1	Follow-up check-in	Patient wellbeing, answer questions	Text message
Day 7	Satisfaction survey + Google review request	Capture feedback, build GBP review velocity	Email + text
Day 30	Detailed outcome survey + referral ask	Outcome data collection, activate word-of-mouth	Email
Day 90	Long-term follow-up + case study consent request	Durability tracking, content pipeline for advocacy	Email

Conversion Optimization Triggers

Trigger Event	Action	Timing	Owner
Form submitted, no callback within 2 hours	Alert: "Hot lead — call now" to clinic	Immediate	CRM automation
Consultation booked, not attended	Re-engagement email: "We saved your spot"	Day after missed	Email automation
Consultation completed, no procedure scheduled within 14 days	Follow-up call from clinic: "Any questions we can answer?"	Day 14	Clinical team
Procedure completed	Post-procedure instructions (email + text)	Immediately	Email automation
Day 7 post-procedure	Satisfaction survey + Google review link	Day 7	Email automation
Day 30 post-procedure, NPS ≥ 9	Referral request: "Know someone who could benefit?"	Day 30	Email automation
Day 90 post-procedure, NPS ≥ 9	Case study consent request	Day 90	Marketing

Platform Status & Launch Readiness

Platform	Role	Current Status	Priority	Owner	Target Launch Week
Website (FAST brand)	Conversion endpoint for all traffic	Not built	P0	Marketing + Dev	Week 1-4
GA4 + GTM	Tracking, attribution, conversion measurement	Not configured	P0	Marketing	Week 1-2
Google Business Profile	Local search, reviews, "near me" queries	Not claimed	P0	Marketing	Week 1-2
Google Ads	Primary paid acquisition channel	Not created	P0	Marketing	Week 4-6
CRM (HubSpot)	Lead management, pipeline tracking	Not configured	P0	Marketing + Sales	Week 2-4
CallRail	Call tracking, attribution	Not configured	P1	Marketing	Week 4-6
Email / SMS (nurture)	Pre-consultation nurture, post-procedure activation	Not configured	P1	Marketing	Week 4-8
Meta Ads	Awareness and retargeting	Not created	P2	Marketing	Week 8-12
SEO content	Organic traffic, authority building	Not started	P1	Marketing	Week 2+ (ongoing)
Healthgrades / RealSelf	Third-party credibility, physician profiles	Not created	P1	Marketing	Week 4-8
Influencer / KOL	Earned credibility, awareness	Not started	P2	Marketing	Week 12+

30/60/90 Day Plan

Four phases — foundation, demand capture, conversion optimization, and scale.

Phase 1: Days 1-30 — Foundation

Build what everything else depends on. No marketing spend has a destination without a tracked website, CRM, and GBP listing. Every subsequent phase gates on these deliverables.

Action	Owner	Dependency	Success Metric
Build and launch FAST website (procedure page, evidence page, physician bios, FAQ, contact form, Seattle location)	Amanda + Dev	None — this gates everything	Website live with all 6 pages
Configure GA4 + GTM (conversion events: form_submit, phone_click, page_view)	Amanda	Website live	Conversion tracking verified
Claim and optimize GBP (complete profile, photos, booking link, first 4 posts)	Amanda	Clinic address confirmed	GBP live with 100% profile completion
Set up CRM — HubSpot (lead stages, pipeline, contact properties, deal tracking)	Amanda	None	First test lead flows through pipeline
Begin SEO content production (5 foundational pages + 2 blog posts)	Amanda + Writer	Website live	7 pages published, schema markup verified
Configure CallRail (call tracking numbers, HIPAA recording, GA4 integration)	Amanda	Google Ads account created	Test call tracked and attributed
Begin physician outreach planning (identify top 50 GI practices within 30 miles)	Gareth	None	Target list finalized, referral packet designed

Exit Criteria — Day 30

Website live with tracking, GBP claimed and optimized, CRM configured, first content published.

Phase 2: Days 30-60 — Demand Capture

Turn on the acquisition engine. Google Ads go live to capture existing search demand. Physician outreach begins to build the highest-margin channel. Email nurture converts leads into consultations.

Action	Owner	Dependency	Success Metric
Launch Google Ads (3 campaigns: treatment-intent, comparison, symptom-intent)	Amanda + MH1	Website live, GA4 configured, CallRail live	Ads live, first clicks tracked
Begin physician outreach (Gareth personal visits with referral packet + published study)	Gareth	Referral packet printed, website live	10+ in-person visits completed
Launch email nurture sequence (3-email series for all new leads)	Amanda + MH1	CRM configured, email templates approved	Sequence live, first leads entering
Create Healthgrades and RealSelf physician profiles	Amanda	Physician bios finalized	Profiles live with complete information
Publish 4 additional SEO content pieces (comparison + symptom articles)	Amanda + Writer	None	4 articles published, indexing confirmed
Set up retargeting audiences (Google Display + Meta pixel)	Amanda + MH1	500+ website visitors (pixel data)	Audiences building, not yet activating

Exit Criteria — Day 60

Google Ads running with CPL tracking, 10+ physician meetings completed, email nurture active, call tracking live. First leads and consultations.

Phase 3: Days 60-90 — Conversion Optimization

With 60 days of data, optimize every stage of the funnel. A/B test the landing page. Tune Google Ads bids by keyword, device, and time. Launch retargeting. Activate the review flywheel from first procedures.

Action	Owner	Dependency	Success Metric
A/B test landing page variants (headline, CTA placement, proof point emphasis)	Amanda + MH1	200+ leads for statistical significance	Winning variant identified, CVR >8%
Optimize Google Ads (pause low-performing keywords, adjust bids by device/time/location)	Amanda + MH1	60 days of campaign data	CPL trending toward $120
Launch retargeting campaigns (Google Display + Meta, 30-90 day audience window)	Amanda + MH1	Retargeting audiences at 1,000+ users	Retargeting live, incremental conversions tracked
Activate review capture sequence (automated Day 7 + Day 30 post-procedure emails)	Amanda	First procedures completed	First Google reviews posted
Assess physician referral pipeline (which MDs are referring? double outreach to active ones)	Gareth	60 days of referral data	3+ active referring physicians
Plan Meta awareness campaign for Month 3+ launch	Amanda + MH1	Budget approved, creative concepts ready	Campaign brief finalized

Exit Criteria — Day 90

Landing page CVR >8%, Google Ads CPL trending toward $120, retargeting live, first reviews captured. 20-30 procedures/month.

Phase 4: Months 3-6 — Scale

The foundation is proven. Now scale every channel, add Meta awareness, expand the physician network, and begin building the compounding flywheel of reviews, referrals, and organic traffic.

Action	Owner	Dependency	Success Metric
Launch Meta awareness campaign ($2K-$5K/month, Seattle 35-65, educational framing)	Amanda + MH1	Creative approved, pixel audiences built	Awareness campaign live
Scale Google Ads to $10K-$15K/month based on CPL performance	Amanda + MH1	CPL at or below $120	Budget increased, volume scaling
SEO traffic arriving — optimize top-performing content, add internal links	Amanda + Writer	4-6 months of content indexed	Organic sessions 500+/month
Review velocity compounds — target 20+ GBP reviews by Month 6	Amanda + Clinical	Post-procedure review capture active	20+ reviews, 4.7+ rating
Expand physician network to 5+ active referring practices	Gareth	Proven referral outcomes to share	5+ active MDs, 10-28 referrals/month
Pilot influencer/KOL program (1-2 medical professional KOLs)	Amanda + MH1	Compliance framework approved, content reviewed	First KOL content published
Implement persona-based email segmentation (Marcus/Sarah/Robert pathways)	Amanda + MH1	CRM data on lead source and behavior	Segmented sequences active

Exit Criteria — Month 6

40-60 procedures/month, 5+ referring physicians, 20+ GBP reviews, Meta awareness active, SEO organic sessions growing.

Measurement & Success

One north star, 12 KPIs, and three scenario projections for Year 1.

North Star KPI: Monthly Procedures Completed

5-10

Month 1

Infrastructure ramp, first patients

20-30

Month 3

Google Ads + first physician referrals

40-60

Month 6

Multi-channel active, review velocity building

80-100

Month 12

All channels firing, physician network established

Full KPI Dashboard

KPI	Definition	Month 3 Target	Month 12 Target	Owner
Monthly procedures	Procedures completed per month	20-30	80-100	Clinical + Marketing
Revenue	Monthly procedure revenue	$80K-$120K	$320K-$400K	Finance
PAC	Patient acquisition cost (all channels blended)	<$800	<$500	Marketing
CPL	Cost per lead (paid channels)	<$150	<$100	Marketing
Lead → Consult rate	% of leads who book a consultation	>55%	>65%	Marketing + Sales
Consult → Procedure rate	% of consultations resulting in procedure	>40%	>50%	Clinical + Sales
Website sessions	Monthly unique sessions	2,000+	8,000+	Marketing
Landing page CVR	Lead form submission rate	>8%	>12%	Marketing
GBP rating	Google Business Profile average rating	4.5+	4.7+	Marketing + Clinical
Physician referrals/month	Monthly leads from physician channel	5-10	20-30	Gareth + Marketing
Review velocity	New Google reviews per month	5+	10+	Marketing
NPS	Net Promoter Score from post-procedure survey	>70	>75	Clinical

Scenario Analysis — Year 1 Revenue

Scenario	Assumptions	Month 12 Procedures	Month 12 Revenue	Year 1 Total
Conservative	CPL $150, slow ramp, no physician referrals	40-50/mo	$160K-$200K/mo	~$1.5M
Base case	CPL $120, physician channel active by M3	60-80/mo	$240K-$320K/mo	~$2.9M
Optimized	CPL $100, physician + SEO + Meta firing	80-100/mo	$320K-$400K/mo	~$3.8M

What Separates Conservative from Optimized

The difference between $1.5M and $3.8M in Year 1 comes down to three variables: (1) physician referral channel activation timing, (2) landing page conversion rate optimization, and (3) whether Meta awareness drives incremental demand or just redistributes existing search volume. The base case assumes physician referrals activate by Month 3 and that landing page CVR exceeds 10% by Month 6.

Risk Matrix

Risk	Likelihood	Impact	Mitigation
Website launch delayed past June 2026	Medium	Critical — misses Sept demand peak	Parallel workstreams: dev builds while content is written. MVP launch with 3 core pages if needed.
Google Ads CPL exceeds $200 for first 30 days	Medium	High — burns budget before optimization	Start with exact-match keywords only. Cap daily budget at $200. Optimize weekly. Pause underperformers aggressively.
Physician referral channel fails to activate by Month 3	Low-Medium	High — base case revenue depends on it	Gareth begins outreach immediately. Doesn't require clinic to be open. 20 visits before launch is the target.
Negative patient outcome or complication	Low (per published data)	Critical — undermines evidence narrative	Transparent complication disclosure from Day 1. Rapid response protocol. Never promise outcomes beyond published data.
Cash-pay price resistance higher than expected	Medium	Medium — reduces conversion rate	CareCredit/Affirm available from launch. Test $3,500 price point if $4,000 shows >20% price objection rate in consultations.
Regulatory issue with FDA claims on website	Low	Critical — legal and reputational	All copy reviewed against guardrails. No claims from archived explainer video. Legal review before launch.

Day 90 Success Scenarios

Below Expectations

<15 procedures/month
CPL >$200
<3 physician referral relationships
Landing page CVR <5%
0-5 Google reviews

Diagnosis: Infrastructure problem (website/tracking), messaging mismatch, or pricing barrier. Do NOT scale spend — fix the foundation.

Action: Pause Google Ads. Redesign landing page. Test lower price point. Intensify physician outreach.

On Track (Base Case)

20-30 procedures/month
CPL $120-$150
3-5 active referring physicians
Landing page CVR 8-10%
10-15 Google reviews at 4.5+

Diagnosis: Acquisition engine working. Conversion funnel needs optimization but fundamentals are sound.

Action: Scale Google Ads to $10K+. Launch Meta awareness. A/B test landing page for next CVR jump. Continue physician outreach.

Exceeding Expectations

30+ procedures/month
CPL <$120
5+ active referring physicians
Landing page CVR >10%
15+ Google reviews at 4.7+

Diagnosis: Strong product-market fit confirmed. Accelerate expansion planning.

Action: Accelerate physician network expansion. Begin NYC clinic planning. Explore insurance submission timeline. Scale all channels.

FAST by Meribel Health

The Opportunity

Executive Summary

The Three Critical Problems

The Gap Nobody Filled

Zero Infrastructure, Zero Awareness

Clinical Evidence Exists, Isn't Being Used

The Unified Strategy

Growth Operating Principles

Build infrastructure before spending on acquisition

The real competitor is patient inaction

Lead with evidence, not claims

Target the September-November demand peak

Cash-pay is the launch model — not a limitation

Physician referrals are the highest-quality, lowest-cost channel

The brand is FAST, not Meribel Health

The Market

Market Funnel: US to Seattle

Procedure Market Tiers

Revenue Model

Clinic Ramp Projections

Seasonality & Demand Cycles

Critical implication for Seattle launch

GTM Comparable Models

Competitive Landscape

Procedure Comparison

Competitive Deep Dives

CRH O'Regan Is the Primary Competitive Threat

Hemorrhoidectomy Fear Drives the Largest Unmet Demand

THD's Decline Creates a Physician Referral Window

Insurance Is the Medium-Term Unlock, Not the Launch Blocker

White Space Analysis

Competitive Moat Assessment

Future Moats (Must Build)

GBP Review Velocity

SEO Content Authority

Physician Referral Network

Controlled Trial Results (H2 2026+)

Potential Competitive Threats

Defensive Strategy

Win the evidence race

Own the search real estate

Lock physician referral relationships early

Transparent outcomes from day one

The Patient

Patient Intelligence

The Patient Journey

Pain Point Ranking

Fear of surgery pain

Embarrassment barrier

Multi-session fatigue

Insurance uncertainty

Skepticism about "new" procedures

Loss of normal life

Emotional Driver Map

Top 10 Patient Search Intent Themes

Unmet Needs Map

Social Listening Deep Dive

Collection Method

Patient Verbatim Quotes

On Living With It

On Fear of Surgery

On Embarrassment

On Seeking Alternatives

On Post-Procedure Relief

Language Patterns for Ad Copy

Copy Implication

Top 10 Pain Points (Ranked by Frequency)

Unmet Needs (Things Patients Want But Can't Find)

Emotional Spectrum

Trust Hierarchy (What Patients Trust When Evaluating Treatments)

Key Trust-Building Observations

What the Research Changed

The Brand Is FAST, Not "Meribel Health"

TSH Competes With Patient Inaction, Not Surgeons

THD Classified as Investigational — March 2025

The Explainer Video Is a Liability

The Journal Article Has a Data Discrepancy

The Physician Referral Channel Has Near-Zero Competition

Seattle Launch Must Target September-November 2026